Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)
Total visits
| views | |
|---|---|
| A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) | 123 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| Chronic Diabetic Macular Edema.pdf | 264 |
Top country views
| views | |
|---|---|
| United States | 50 |
| China | 29 |
| Portugal | 13 |
| Australia | 11 |
| India | 6 |
| France | 3 |
| Brazil | 2 |
| Canada | 2 |
| Germany | 2 |
| Japan | 1 |
| South Korea | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Durg | 1 |